• 1018 Citations
  • 18 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Research Output 2006 2019

  • 1018 Citations
  • 18 h-Index
  • 94 Article
  • 2 Letter
  • 2 Review article
  • 1 Editorial
2019

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Lomustine
Glioblastoma
Survival
temozolomide
Italy
2018

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

Brandes, A. A., Gil-Gil, M., Saran, F., Carpentier, A. F., Nowak, A. K., Mason, W., Zagonel, V., Dubois, F., Finocchiaro, G., Fountzilas, G., Cernea, D. M., Chinot, O., Anghel, R., Ghiringhelli, F., Beauchesne, P., Lombardi, G., Franceschi, E., Makrutzki, M., Mpofu, C., Urban, H-J. & 1 othersPichler, J., Sep 28 2018, In : The oncologist.

Research output: Contribution to journalArticle

Glioblastoma
Lomustine
Safety
temozolomide
Placebos

Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration

Pasqualetti, F., Gonnelli, A., Molinari, A., Cantarella, M., Montrone, S., Cristaudo, A., Baldaccini, D., Mattioni, R., Delishaj, D., Mazzotti, V., Morganti, R., Cocuzza, P., Fabrini, M. G., Lombardi, G., Rudà, R., Soffietti, R. & Paiar, F., Oct 2018, In : Anticancer Research. 38, 10, p. 5877-5881 5 p.

Research output: Contribution to journalArticle

Glioblastoma
Recurrence
Disease-Free Survival
Bevacizumab
Survival

Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma

Lombardi, G., Puppa, A. D., Gardiman, M. P., Rossi, S., Candiotto, C., Zanatta, L., Bertorelle, R., De Rossi, A., Fassan, M. & Zagonel, V., Jul 5 2018, In : Neuro-Oncology. 20, 8, p. 1142-1143 2 p.

Research output: Contribution to journalLetter

6 Citations (Scopus)

Early recognition of aggressive pituitary adenomas: a single-centre experience

Ceccato, F., Regazzo, D., Barbot, M., Denaro, L., Emanuelli, E., Borsetto, D., Rolma, G., Alessio, L., Gardiman, M. P., Lombardi, G., Albiger, N., D’Avella, D. & Scaroni, C., Jan 1 2018, In : Acta Neurochirurgica. 160, 1, p. 49-55 7 p.

Research output: Contribution to journalArticle

Pituitary Neoplasms
Adenoma
Growth Hormone
Radiotherapy
Prolactin

Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma

Indraccolo, S., Lombardi, G., Fassan, M., Pasqualini, L., Giunco, S., Marcato, R., Gasparini, A., Candiotto, C., Nalio, S., Fiduccia, P., Fanelli, G. N., Pambuku, A., Della Puppa, A., D'Avella, D., Bonaldi, L., Gardiman, M. P., Bertorelle, R., De Rossi, A. & Zagonel, V., Dec 4 2018, In : Clinical Cancer Research.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Glioblastoma
Epigenomics
Tumor Burden
Exome
temozolomide
Glioblastoma
Radiotherapy
Maintenance
Therapeutics

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy

Pasqualetti, F., Orlandi, P., Simeon, V., Cantarella, M., Giuliani, D., Di Desidero, T., Gonnelli, A., Delishaj, D., Lombardi, G., Sechi, A., Sanson, M., Zagonel, V., Paiar, F., Danesi, R., Guarini, S. & Bocci, G., Feb 2018, In : Molecular Neurobiology. p. 1396-1404

Research output: Contribution to journalArticle

Receptor, Melanocortin, Type 4
Glioblastoma
Radio
Disease-Free Survival
Drug Therapy

Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology

Pasqualetti, F., Pace, A., Gonnelli, A., Villani, V., Cantarella, M., Delishaj, D., Vivaldi, C., Molinari, A., Montrone, S., Pellerino, A., Franchino, F., Baldaccini, D., Lombardi, G., Lolli, I., Catania, F., Bazzoli, E., Morganti, R., Fabi, A., Zagonel, V., Bocci, G. & 4 othersFabrini, M. G., Rudà, R., Soffietti, R. & Paiar, F., Dec 2018, In : American Journal of Clinical Oncology. 41, 12, p. 1272-1275 4 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Drug Therapy
Confidence Intervals
Angiogenesis Inhibitors

Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma

Ferrara, A. M., Lombardi, G., Pambuku, A., Meringolo, D., Bertorelle, R., Nardin, M., Schiavi, F., Iacobone, M., Opocher, G., Zagonel, V. & Zovato, S., Jan 1 2018, In : Anti-Cancer Drugs. 29, 1, p. 102-105 4 p.

Research output: Contribution to journalArticle

temozolomide
Paraganglioma
Pheochromocytoma
Therapeutics
Catecholamines
2017
6 Citations (Scopus)

Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management

Luck, S. E., Wieringa, J. W., Blazquez-Gamero, D., Henneke, P., Schuster, K., Butler, K., Capretti, M. G., Cilleruelo, M. J., Curtis, N., Garofoli, F., Heath, P., Iosifidis, E., Klein, N., Lombardi, G., Lyall, H., Nieminen, T., Pajkrt, D., Papaevangelou, V., Posfay-Barbe, K., Puhakka, L. & 8 othersRoilides, E., Rojo, P., Saavedra-Lozano, J., Shah, T., Sharland, M., Saxen, H., Vossen, A. C. T. M. & ESPID Congenital CMV Group Meeting, L. ., Dec 1 2017, In : Pediatric Infectious Disease Journal. 36, 12, p. 1205-1213 9 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Fabi, A., Caserta, C., Tosoni, A., Eoli, M., Lombardi, G., Clavarezza, M., Paccapelo, A., Bartolini, S., Cirillo, L., Agati, R. & Franceschi, E., 2017, In : Oncotarget. 8, 33, p. 55575-55581 7 p.

Research output: Contribution to journalArticle

Glioblastoma
Survival
Neoplasms
fotemustine
Angiogenesis Inhibitors
26 Citations (Scopus)

Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials

Lombardi, G., Pambuku, A., Bellu, L., Farina, M., Della Puppa, A., Denaro, L. & Zagonel, V., Mar 1 2017, In : Critical Reviews in Oncology/Hematology. 111, p. 94-102 9 p.

Research output: Contribution to journalReview article

Glioblastoma
Meta-Analysis
Randomized Controlled Trials
Pharmaceutical Preparations
Combination Drug Therapy

Elderly patients with glioblastoma: Where are we going?

Lombardi, G., Pambuku, A. & Zagonel, V., Aug 1 2017, In : Translational Cancer Research. 6, p. S1022-S1024

Research output: Contribution to journalEditorial

3 Citations (Scopus)

Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy

Pasqualetti, F., Orlandi, P., Simeon, V., Cantarella, M., Giuliani, D., Di Desidero, T., Gonnelli, A., Delishaj, D., Lombardi, G., Sechi, A., Sanson, M., Zagonel, V., Paiar, F., Danesi, R., Guarini, S. & Bocci, G., Feb 1 2017, In : Molecular Neurobiology.

Research output: Contribution to journalArticle

Receptor, Melanocortin, Type 4
Glioblastoma
Radio
Disease-Free Survival
Drug Therapy
4 Citations (Scopus)

Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up

della Puppa, A., Lombardi, G., Rossetto, M., Rustemi, O., Berti, F., Cecchin, D., Gardiman, M. P., Rolma, G., Persano, L., Zagonel, V. & Scienza, R., Jan 2017, In : Journal of Neuro-Oncology. 131, 2, p. 331-40 10 p.

Research output: Contribution to journalArticle

Carmustine
Aminolevulinic Acid
Glioblastoma
Survival
Survivors
2016
11 Citations (Scopus)

Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma

Labussière, M., Cheneau, C., Prahst, C., Gállego Pérez-Larraya, J., Farina, P., Lombardi, G., Mokhtari, K., Rahimian, A., Delattre, J. Y., Eichmann, A. & Sanson, M., Jan 2 2016, In : Cancer Investigation. 34, 1, p. 39-44 6 p.

Research output: Contribution to journalArticle

Angiopoietin-2
Glioblastoma
Vascular Endothelial Growth Factor A
Recurrence
Appointments and Schedules
9 Citations (Scopus)

Annexin 2A sustains glioblastoma cell dissemination and proliferation

Maule, F., Bresolin, S., Rampazzo, E., Boso, D., Della Puppa, A., Esposito, G., Porcù, E., Mitola, S., Lombardi, G., Accordi, B., Tumino, M., Basso, G. & Persano, L., 2016, In : Oncotarget. 7, 34, p. 54632-54649 18 p.

Research output: Contribution to journalArticle

Annexins
Glioblastoma
Cell Proliferation
Neoplasms
Brain Neoplasms

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival
14 Citations (Scopus)

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A. A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Brandes, A., Finocchiaro, G., Zagonel, V., Reni, M., Caserta, C., Fabi, A., Clavarezza, M., Maiello, E., Eoli, M., Lombardi, G., Monteforte, M., Proietti, E., Agati, R., Eusebi, V. & Franceschi, E., Sep 1 2016, In : Neuro-Oncology. 18, 9, p. 1304-1312 9 p.

Research output: Contribution to journalArticle

fotemustine
Glioblastoma
Confidence Intervals
Survival Rate
Survival
4 Citations (Scopus)
fotemustine
Glioblastoma
Appointments and Schedules
Retrospective Studies
temozolomide
10 Citations (Scopus)

Cognitive Rehabilitation in Patients with Gliomas and Other Brain Tumors: State of the Art

Bergo, E., Lombardi, G., Pambuku, A., Della Puppa, A., Bellu, L., D'avella, D. & Zagonel, V., 2016, In : BioMed Research International. 2016, 3041824.

Research output: Contribution to journalReview article

Brain Neoplasms
Glioma
Patient rehabilitation
Tumors
Brain

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics
13 Citations (Scopus)
Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: A randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

Mazza, E. A., Brandes, A., Zanon, S., Eoli, M., Lombardi, G., Faedi, M., Franceschi, E. & Reni, M., Jan 1 2016, In : Cancer Chemotherapy and Pharmacology. 77, 1, p. 115-120 6 p.

Research output: Contribution to journalArticle

Hydroxyurea
Meningioma
Surgery
Toxicity
Therapeutics
1 Citation (Scopus)

Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy

Nicoletto, M. O., Casarin, A., Baldoni, A., Rulli, E., Tasca, G., Baretta, Z., Artioli, G., Lombardi, G., Cappetta, A., Floriani, I., Randon, G., Valpione, S., Litta, P., Conte, P., Mocellin, S. & Aliberti, C., Dec 1 2016, In : Anticancer Research. 36, 12, p. 6541-6546 6 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Drug Therapy
Platinum
Survival
Therapeutics

Intraperitoneal chemotherapy in patients pretreated for ovarian cancer matched with patients treated with parenteral chemotherapy

Nicoletto, M. O., Casarin, A., Baldoni, A., Rulli, E., Tasca, G., Baretta, Z., Artioli, G., Lombardi, G., Cappetta, A., Floriani, I., Randon, G., Valpione, S., Litta, P., Conte, P., Mocellin, S. & Aliberti, C., Dec 1 2016, In : Anticancer Research. 36, 12, p. 6541-6546 6 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Surgery on motor area metastasis

Rossetto, M., Ciccarino, P., Lombardi, G., Rolma, G., Cecchin, D. & Della Puppa, A., Jan 1 2016, In : Neurosurgical Review. 39, 1, p. 71-78 8 p.

Research output: Contribution to journalArticle

Motor Cortex
Karnofsky Performance Status
Neoplasm Metastasis
Neurophysiological Monitoring
Tumor Burden

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

temozolomide
Pituitary Neoplasms
Therapeutics

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

temozolomide
Pituitary Neoplasms
Therapeutics

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

temozolomide
Pituitary Neoplasms
Therapeutics
34 Citations (Scopus)

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

Losa, M., Bogazzi, F., Cannavo, S., Ceccato, F., Curtò, L., De Marinis, L., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E., Minniti, G., Nizzoli, M., Reni, M. & Scaroni, C., Feb 1 2016, In : Journal of Neuro-Oncology. 126, 3, p. 519-525 7 p.

Research output: Contribution to journalArticle

temozolomide
Pituitary Neoplasms
Therapeutics
1 Citation (Scopus)

The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 2

Cabibbo, G., Reig, M., Gadaleta-Caldarola, G., Galati, G., Lombardi, G., Mazza, G. C., Marzi, L., Saitta, C., Nault, J. C. & Sacco, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

Paris
Liver Neoplasms
France
Gastroenterology
3 Citations (Scopus)

The calm before the storm: A report from the International Liver Cancer Association Congress 2015 - Part 1

Cabibbo, G., Reig, M., Gadaleta-Caldarola, G., Galati, G., Lombardi, G., Mazza, G. C., Marzi, L., Saitta, C., Nault, J. C. & Sacco, R., Feb 1 2016, In : Future Oncology. 12, 3, p. 281-284 4 p.

Research output: Contribution to journalArticle

Paris
Liver Neoplasms
France
Gastroenterology

The Three Players of Mechanical Valve Thrombosis: Cancer, Anticancer Therapy, and Thromboprophylaxis

Banzato, A., Denas, G., Lombardi, G., Pambuku, A., Bianchi, A. & Pengo, V., Jul 2016, In : Journal of Heart Valve Disease. 25, 4, p. 522-524 3 p.

Research output: Contribution to journalArticle

Prostheses and Implants
Thrombosis
Neoplasms
Low Molecular Weight Heparin
Heart Valves
2 Citations (Scopus)

Urine 2-hydroxyglutarate in Glioma

Lombardi, G., Puppa, A. D. & Zagonel, V., Aug 1 2016, In : Oncologist. 21, 8, p. 1026 1 p.

Research output: Contribution to journalLetter

2015
8 Citations (Scopus)

Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results

Zustovich, F., Ferro, A., Lombardi, G., Farina, P. & Zagonel, V., Nov 5 2015, In : Chemotherapy. 60, 5-6, p. 294-299 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Brain
gemcitabine
Disease-Free Survival
15 Citations (Scopus)
temozolomide
Glioblastoma
Prospective Studies
Radiation
Radiotherapy
19 Citations (Scopus)

Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma

Lombardi, G., Corona, G., Bellu, L., Puppa, A. D., Pambuku, A., Fiduccia, P., Bertorelle, R., Gardiman, M. P., D’avella, D., Toffoli, G. & Zagonel, V., 2015, In : The oncologist. 20, 5, p. 562-567 6 p.

Research output: Contribution to journalArticle

Isocitrate Dehydrogenase
Glioma
Urine
Mutation
alpha-hydroxyglutarate
6 Citations (Scopus)
Glioblastoma
Quality of Life
Glioma
Morbidity
Therapeutics
4 Citations (Scopus)

Open Transcranial Resection of Small (

Della Puppa, A., D'Avella, E., Rossetto, M., Volpin, F., Rustemi, O., Gioffrè, G., Lombardi, G., Rolma, G. & Scienza, R., Sep 1 2015, In : World Neurosurgery. 84, 3, p. 741-750 10 p.

Research output: Contribution to journalArticle

Microsurgery
Meningioma
Radiosurgery
Vision Disorders
Skull Base
19 Citations (Scopus)

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

Lombardi, G., Pace, A., Pasqualetti, F., Rizzato, S., Faedi, M., Anghileri, E., Nicolotto, E., Bazzoli, E., Bellu, L., Villani, V., Fabi, A., Ferrazza, P., Gurrieri, L., Dall’Agata, M., Eoli, M., Della Puppa, A., Pambuku, A., D’Avella, D., Berti, F., Rudà, R. & 1 othersZagonel, V., Nov 1 2015, In : Journal of Neuro-Oncology. 125, 2, p. 359-367 9 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Multicenter Studies
Retrospective Studies
Survival
29 Citations (Scopus)

Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center

Ceccato, F., Lombardi, G., Manara, R., Emanuelli, E., Denaro, L., Milanese, L., Gardiman, M. P., Bertorelle, R., Scanarini, M., D’Avella, D., Occhi, G., Boscaro, M., Zagonel, V. & Scaroni, C., 2015, In : Journal of Neuro-Oncology. 122, 1, p. 189-196 8 p.

Research output: Contribution to journalArticle

temozolomide
Pituitary Neoplasms
Tertiary Care Centers
Adrenocorticotropic Hormone
Therapeutics
17 Citations (Scopus)

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab

Di Stefano, A. L., Labussiere, M., Lombardi, G., Eoli, M., Bianchessi, D., Pasqualetti, F., Farina, P., Cuzzubbo, S., Gallego-Perez-Larraya, J., Boisselier, B., Ducray, F., Cheneau, C., Moglia, A., Finocchiaro, G., Marie, Y., Rahimian, A., Hoang-Xuan, K., Delattre, J. Y., Mokhtari, K. & Sanson, M., 2015, In : Journal of Neuro-Oncology. 121, 3, p. 499-504 6 p.

Research output: Contribution to journalArticle

Glioblastoma
Single Nucleotide Polymorphism
Blood Vessels
temozolomide
Genotype
2014
36 Citations (Scopus)

5-aminolevulinic acid fluorescence in high grade glioma surgery: Surgical outcome, intraoperative findings, and fluorescence patterns

Puppa, A. D., Ciccarino, P., Lombardi, G., Rolma, G., Cecchin, D. & Rossetto, M., 2014, In : BioMed Research International. 2014, 232561.

Research output: Contribution to journalArticle

Aminolevulinic Acid
Glioma
Surgery
Tumors
Fluorescence
4 Citations (Scopus)

An overview of fotemustine in high-grade gliomas: From single agent to association with bevacizumab

Lombardi, G., Farina, P., Della Puppa, A., Cecchin, D., Pambuku, A., Bellu, L. & Zagonel, V., 2014, In : BioMed Research International. 2014, 698542.

Research output: Contribution to journalArticle

fotemustine
temozolomide
Glioma
Lomustine
Safety
1 Citation (Scopus)

Assessing response using Tc 99 m -MIBI early after interstitial chemotherapy with carmustine-loaded polymers in glioblastoma multiforme: Preliminary results

Cecchin, D., Schiorlin, I., Della Puppa, A., Lombardi, G., Zucchetta, P., Bodanza, V., Gardiman, M. P., Rolma, G., Frigo, A. C. & Bui, F., 2014, In : BioMed Research International. 2014, 684383.

Research output: Contribution to journalArticle

Carmustine
Chemotherapy
Glioblastoma
Polymers
Drug Therapy